Research Peptide

5-Amino-1MQ

5-Amino, NNMT inhibitor

Category: Weight Loss    

Molecular Structure

2D molecular structure of the 5-Amino-1MQ research peptide

Chemical Properties

Molecular Mass: 159.21 g/mol

Molecular Formula: C10H11N2

CAS Number: 424912-40-5

Sequence: N/A

  • 5-Amino-1MQ does not have an amino acid sequence because it is a synthetic small molecule organic compound, not a peptide. 

Half-Life: Approxmately 6-12 hours

Typical Purity: >98%

Administration Routes: subcutaneous, oral

Overview

5-Amino-1MQ is a small-molecule research compound that has been examined in laboratory studies as an inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme found in several tissue types. It is included in research libraries as a chemical tool for probing NNMT-related biology in experimental models.

 

Research Background

NNMT was identified by researchers as an enzyme that transfers a methyl group from S-adenosyl-L-methionine (SAM) to nicotinamide, generating 1-methylnicotinamide (1-MNA) and S-adenosyl-L-homocysteine (SAH). Because this reaction sits at a junction between methylation chemistry and nicotinamide/NAD+ metabolism, NNMT drew scientific interest as a potential regulator of broader cellular processes.

A 2014 study examining reduced NNMT activity in fat cell models reported changes in body composition, glucose handling, and energy expenditure measures in mice. This work helped establish NNMT as a molecular target for further mechanistic study. Quinolinium-based NNMT inhibitors, including 5-Amino-1MQ, were subsequently reported in the scientific literature beginning in the late 2010s as chemical tools for testing this target in cell and animal models.

 

Mechanism of Action

Published research describes 5-Amino-1MQ as a substrate-competitive NNMT inhibitor, meaning it interacts with the region of the enzyme responsible for binding nicotinamide and SAM. By occupying this site, the compound has been reported to interfere with NNMT’s catalytic activity in experimental systems.

Because NNMT sits within both methylation chemistry (via SAM/SAH) and nicotinamide handling (linked to NAD+ salvage), inhibiting the enzyme has been studied as a way to examine downstream effects across several connected cellular pathways rather than a single isolated mechanism.

 

Research Areas

Published laboratory research involving 5-Amino-1MQ has explored several biological systems:

  • Metabolism and adipose tissue biology: Studies in diet-induced obesity models in mice have examined fat tissue accumulation, glucose handling, and liver triglyceride levels following NNMT inhibition.
  • Skeletal muscle biology: Preclinical research has investigated NNMT’s role in muscle stem cell activity, muscle tissue regeneration models, and age-related changes in muscle physiology.
  • NAD+ and methylation pathways: Because NNMT consumes both nicotinamide and SAM, laboratory studies have used 5-Amino-1MQ to probe how NNMT inhibition intersects with NAD+ salvage biochemistry and cellular methylation balance.
  • Oncology-related models: NNMT expression changes have been observed in certain cancer cell models, prompting some laboratory investigation of NNMT inhibition in this context.

Only research areas supported by published preclinical literature are reflected here.

 

Research Status

5-Amino-1MQ remains an investigational research compound. Published findings to date are derived from in vitro and animal model systems; results observed in these models cannot be assumed to translate to other biological systems. Limited published clinical research exists, but additional investigation is needed to further characterize its biological properties.

NNMT itself is a well-characterized enzyme with defined catalytic activity, but the broader physiological role of NNMT inhibition — and the significance of findings from preclinical models — continues to be an active area of scientific inquiry.

 

Regulatory Status

5-Amino-1MQ is an investigational research compound and has not been approved by the U.S. Food and Drug Administration (FDA). It is not evaluated by the World Anti-Doping Agency (WADA) for a defined regulatory category at this time. This compound is intended strictly for laboratory research use.

 

Laboratory Storage

  • Store as a dry powder in a sealed container, protected from light and moisture.
  • General laboratory reference sources indicate stability at room temperature for short-term handling, with refrigeration (2–8°C) or freezing recommended for longer-term storage.
  • Reconstituted or solubilized material (e.g., in DMSO or aqueous buffer) is generally handled per standard laboratory practice for small-molecule reagents and stored frozen when not in immediate use.
  • Laboratories should follow their own standard operating procedures and the specific certificate of analysis for the lot in question.

 

Research Use Only: 5-Amino-1MQ is intended exclusively for laboratory research and analytical purposes. It is an investigational research compound and has not been approved by the U.S. Food and Drug Administration (FDA). 

Interaction Matrix

Synergistic:

  • NAD+: Laboratory studies suggest 5-Amino-1MQ and NAD+ may interact through the NAD+ salvage pathway. This relationship has only been investigated in preclinical models and has not been evaluated in human trials.
  • L-Carnitine: L-Carnitine has been studied separately in the context of fatty acid transport and mitochondrial metabolism. Published research has not established a mechanistic or clinical relationship between L-Carnitine and NNMT-related pathways specifically.

Compatible:

  • Semaglutide/Tirzepetide/Retatrutide: Research indicates it targets fat loss through different pathways — appetite suppression and increased metabolic activity

Caution: 

  • N/A

Frequently Asked Questions

  1. What is 5-Amino-1MQ? It is a small-molecule quinolinium derivative studied in laboratory research as an inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT).
  2. What has 5-Amino-1MQ been researched for? Published laboratory studies have examined it in experimental models related to adipose tissue biology, glucose metabolism, skeletal muscle biology, and NAD+/methylation pathways.
  3. How does 5-Amino-1MQ work? Research describes it as a substrate-competitive inhibitor that interacts with the nicotinamide- and SAM-binding region of the NNMT enzyme, interfering with its catalytic activity in experimental systems.
  4. What makes 5-Amino-1MQ unique among NNMT-targeting compounds? It has been characterized in published literature as a selective, substrate-site-targeting NNMT inhibitor, distinguishing it from earlier non-selective methyltransferase inhibitors used in research.
  5. Is 5-Amino-1MQ approved by the FDA? No. It is an investigational research compound and has not been approved by the U.S. Food and Drug Administration for any use.
  6. What is known about the half-life of 5-Amino-1MQ? Limited published clinical research exists, but additional investigation is needed to further characterize its biological properties.
  7. Does 5-Amino-1MQ have an amino acid sequence? No. Unlike peptides, 5-Amino-1MQ is a small-molecule quinolinium compound and does not have an amino acid sequence.
  8. How should 5-Amino-1MQ be stored in a laboratory setting? General laboratory guidance calls for storage as a sealed, dry powder protected from light and moisture, with refrigeration or freezing for longer-term stability. Laboratories should refer to the certificate of analysis for lot-specific handling.
  9. What is the current state of research on 5-Amino-1MQ? Current evidence is derived from in vitro and animal model studies. NNMT is a well-studied enzyme, but the broader significance of NNMT inhibition remains an active research question, and preclinical findings have not been established in other model systems.
  10. What areas continue to be investigated? Ongoing published research continues to examine NNMT’s role in metabolic signaling, skeletal muscle biology, NAD+ salvage pathways, and cellular methylation processes.

Research Use Only: 5-Amino-1MQ  is intended exclusively for laboratory research and analytical purposes. It is an investigational research compound and has not been approved by the U.S. Food and Drug Administration (FDA).


Research Use Only

This information is provided for educational and scientific research purposes only. Products offered by Flatirons Research Co are intended strictly for laboratory and research use and are not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of disease. Nothing on this page constitutes medical advice, dosing guidance, or a recommendation for clinical use.